127 related articles for article (PubMed ID: 8743819)
21. Endocrine pancreatic carcinoma.
Rothmund M; Stinner B; Arnold R
Eur J Surg Oncol; 1991 Apr; 17(2):191-9. PubMed ID: 1849844
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic mixed ductal-islet tumors. Is this an entity?
Permert J; Mogaki M; Andrén-Sandberg A; Kazakoff K; Pour PM
Int J Pancreatol; 1992 Feb; 11(1):23-9. PubMed ID: 1316418
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
25. Characterization of immunoreactive forms of pancreatic polypeptide in islet cell tumors using antisera with different regional specificities.
O'Hare MM; Huda I; Sloan JM; Kennedy TL; Buchanan KD
Cancer; 1985 May; 55(9):1895-8. PubMed ID: 2983868
[TBL] [Abstract][Full Text] [Related]
26. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
Barton CM; Staddon SL; Hughes CM; Hall PA; O'Sullivan C; Klöppel G; Theis B; Russell RC; Neoptolemos J; Williamson RC
Br J Cancer; 1991 Dec; 64(6):1076-82. PubMed ID: 1764370
[TBL] [Abstract][Full Text] [Related]
27. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma.
DiGiuseppe JA; Redston MS; Yeo CJ; Kern SE; Hruban RH
Am J Pathol; 1995 Oct; 147(4):884-8. PubMed ID: 7573363
[TBL] [Abstract][Full Text] [Related]
28. Somatostatin-28 like immunoreactivity in normal and tumour tissue from duodenum and pancreas.
Ito S; Yamada Y; Iwanaga T; Kaneko H; Shibata A
Acta Endocrinol (Copenh); 1982 Nov; 101(3):421-7. PubMed ID: 6293233
[TBL] [Abstract][Full Text] [Related]
29. Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas.
Borka K; Kaliszky P; Szabó E; Lotz G; Kupcsulik P; Schaff Z; Kiss A
Virchows Arch; 2007 May; 450(5):549-57. PubMed ID: 17429687
[TBL] [Abstract][Full Text] [Related]
30. Amyloid protein in somatostatinoma differs from human islet amyloid polypeptide.
Ohsawa H; Kanatsuka A; Tokuyama Y; Yamaguchi T; Makino H; Yoshida S; Horie H; Mikata A; Kohen Y
Acta Endocrinol (Copenh); 1991 Jan; 124(1):45-53. PubMed ID: 2000701
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of heat shock protein (hsp) 70 associated with abnormal p53 expression in cancer of the pancreas.
Lee CS; Montebello J; Rush M; Georgiou T; Wawryk S; Rode J
Zentralbl Pathol; 1994 Aug; 140(3):259-64. PubMed ID: 7947633
[TBL] [Abstract][Full Text] [Related]
32. Expression of peptide receptors in human endocrine tumours of the pancreas.
Tang C; Biemond I; Lamers CB
Gut; 1997 Feb; 40(2):267-71. PubMed ID: 9071943
[TBL] [Abstract][Full Text] [Related]
33. [A glucagon-secreting alpha-cell carcinoma of the pancreas].
Matsumoto J; Noto N; Kikuchi Y; Kitazima S; Kaimori M; Sasaki G; Ohto T; Nakamura K
Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):330-4. PubMed ID: 2987580
[No Abstract] [Full Text] [Related]
34. bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.
Sinicrope FA; Evans DB; Leach SD; Cleary KR; Fenoglio CJ; Lee JJ; Abbruzzese JL
Clin Cancer Res; 1996 Dec; 2(12):2015-22. PubMed ID: 9816161
[TBL] [Abstract][Full Text] [Related]
35. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas.
Boschman CR; Stryker S; Reddy JK; Rao MS
Am J Pathol; 1994 Dec; 145(6):1291-5. PubMed ID: 7992834
[TBL] [Abstract][Full Text] [Related]
36. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic polypeptide islet cell tumor: case report and review of the literature.
Bellows C; Haque S; Jaffe B
J Gastrointest Surg; 1998; 2(6):526-32. PubMed ID: 10457310
[TBL] [Abstract][Full Text] [Related]
38. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
39. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
Long KB; Srivastava A; Hirsch MS; Hornick JL
Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
[TBL] [Abstract][Full Text] [Related]
40. Expression of p53 protein in pancreatic adenocarcinoma. Relationship to cigaret smoking.
Lee EU; Cibull ML; O'Daniel-Pierce E; Strodel WE; Jennings CD
Int J Pancreatol; 1995 Jun; 17(3):237-42. PubMed ID: 7642971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
